BHC

Bausch Health Companies Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

17.19
+0.04
+0.23%
After Hours: 17.20 +0.01 +0.06% 19:31 07/10 EDT
OPEN
17.05
PREV CLOSE
17.15
HIGH
17.33
LOW
16.93
VOLUME
2.69M
TURNOVER
--
52 WEEK HIGH
31.97
52 WEEK LOW
11.15
MARKET CAP
6.10B
P/E (TTM)
-3.2112
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BHC stock price target is 27.76 with a high estimate of 64.00 and a low estimate of 14.00.

EPS

BHC News

More
Did Hedge Funds Make The Right Call On Bausch Health Companies Inc. (BHC) ?
Insider Monkey · 2d ago
Bausch Health: Setting Its Sights On Eye Care
Seeking Alpha - Article · 07/03 10:14
Bausch Health: Investors Were Acknowledging The Turnaround Before COVID-19 Struck
Seeking Alpha - Article · 07/02 21:22
John Paulson is reportedly winding down his hedge funds. These were his last big bets
John Paulson's hedge funds were well-positioned for the historic market turmoil earlier this year with his big bets on gold.
CNBC.com · 07/01 15:15
Bill Ackman on Becoming an Activist Investor
GuruFocus.com · 06/29 23:37
Sol-Gel inks deal for three new generic product candidates with Perrigo
Seeking Alpha - Article · 06/29 12:38
Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product Candidates
Sol-Gel Technologies, Ltd. (SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that it has entered into collaborative
GlobeNewswire · 06/29 11:00
Top investor Bill Ackman wants to buy a unicorn
CNN.com · 06/29 04:00

Industry

Pharmaceuticals
-0.31%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Symbol
Price
%Change

About BHC

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
More

Webull offers kinds of Bausch Health Companies Inc stock information, including NYSE:BHC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BHC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BHC stock methods without spending real money on the virtual paper trading platform.